Urgent care market braces for CVS and Walgreens entry

February 04, 2016 A new report predicts significant growth in the urgent care niche over the next several years, likely with greater participation by community pharmacy chains such as CVS and Walgreens. While neither brand intends to directly enter the business, both...

FDA approves long-acting ADHD drug

February 04, 2016 FDA has approved a longer-acting version of amphetamine (Adzenys XR-ODT—Neos Therapeutics) for the treatment of ADHD. The orally disintegrating tablet was approved to treat ADHD in patients aged 6 years and older. The drug, which FDA had rejected 3...

FDA approves long-acting ADHD drug

February 04, 2016 FDA has approved a longer-acting version of amphetamine (Adzenys XR-ODT—Neos Therapeutics) for the treatment of ADHD. The orally disintegrating tablet was approved to treat ADHD in patients aged 6 years and older. The drug, which FDA had rejected 3...